Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma
- 15 August 2001
- Vol. 92 (4) , 830-835
- https://doi.org/10.1002/1097-0142(20010815)92:4<830::aid-cncr1389>3.0.co;2-c
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinomaCancer, 2000
- Phase I/II Study of Gemcitabine Plus Vinorelbine as First-Line Chemotherapy of Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000
- Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1998
- Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II studyEuropean Journal Of Cancer, 1997
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- New aspects in the staging of lung cancer. Prospective validation of the international union against cancer TNM classificationCancer, 1992
- Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.Journal of Clinical Oncology, 1990
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958